IT1238011B - Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. - Google Patents
Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna.Info
- Publication number
- IT1238011B IT1238011B IT04865889A IT4865889A IT1238011B IT 1238011 B IT1238011 B IT 1238011B IT 04865889 A IT04865889 A IT 04865889A IT 4865889 A IT4865889 A IT 4865889A IT 1238011 B IT1238011 B IT 1238011B
- Authority
- IT
- Italy
- Prior art keywords
- hmg
- treatment
- prostatic hypertrophy
- pharmaceutical composition
- coa reductase
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT04865889A IT1238011B (it) | 1989-12-13 | 1989-12-13 | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT04865889A IT1238011B (it) | 1989-12-13 | 1989-12-13 | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. |
Publications (3)
Publication Number | Publication Date |
---|---|
IT8948658A0 IT8948658A0 (it) | 1989-12-13 |
IT8948658A1 IT8948658A1 (it) | 1991-06-13 |
IT1238011B true IT1238011B (it) | 1993-06-21 |
Family
ID=11267879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IT04865889A IT1238011B (it) | 1989-12-13 | 1989-12-13 | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1238011B (it) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026300A1 (en) * | 2002-09-17 | 2004-04-01 | Pfizer Limited | COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS |
WO2005089804A2 (en) * | 2004-03-16 | 2005-09-29 | Pfizer Limited | Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
-
1989
- 1989-12-13 IT IT04865889A patent/IT1238011B/it active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004026300A1 (en) * | 2002-09-17 | 2004-04-01 | Pfizer Limited | COMBINATIONS OF ATORVASTATIN AND α1, ADRENERGIC RECEPTOR ANTAGONISTS |
WO2005089804A2 (en) * | 2004-03-16 | 2005-09-29 | Pfizer Limited | Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
WO2005089804A3 (en) * | 2004-03-16 | 2006-05-18 | Pfizer Ltd | Combinations of hmg-coa reductase inhibitors and alpha1 adrenergic receptor antagonists |
Also Published As
Publication number | Publication date |
---|---|
IT8948658A0 (it) | 1989-12-13 |
IT8948658A1 (it) | 1991-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE319447T1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
ATE177949T1 (de) | Kombinationstherapie zur prophylaxe und/oder behandlung benigner prostatahyperplasie | |
GEP20032869B (en) | Alpha -Ketoamide Inhibitors of 20S Proteasome, Pharmaceutical Preparations Containing the Same and Methods for Treatment | |
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
ES2128552T3 (es) | Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama. | |
GEP20033117B (en) | Hydroxy Pipecolate Hydroxamic Acid Derivatives as MMP Inhibitors, Pharmaceutical Compositions Containing Them and Their Use for Treatment of Diseases caused by MMP | |
HK1001973A1 (en) | Sulfonamides | |
AU2002236765A1 (en) | Pharmaceutical combination for the treatment of cancer containing a 4-quinazolineamine and another anti-neoplastic agent | |
EE05025B1 (et) | Fumaarhappe derivaadid kasutamiseks transplantaadivastase reaktsiooni raviks | |
BR0110420A (pt) | Agonistas muscarìnicos | |
EP0667769A4 (en) | USE OF SPECIFIC ALPHA-1C COMPOUNDS IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA. | |
NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
PL329802A1 (en) | Derivatives of androstene | |
TR199901604T2 (xx) | Tedavide yararl� kinolin ve kinazolin bile�ikleri. | |
GEP20043322B (en) | C7 Ester Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof for Inhibiting Tumors | |
TR200100774T2 (tr) | Bir aP2 önleyicisinin ve kombinasyonunun kullanıldığı aterosklerozis tedavi yöntemi | |
IL110943A0 (en) | Compositions for the treatment of skin disorders | |
CY1111869T1 (el) | Φαρμακευτικες συνθεσεις και μεθοδοι χρησιμες για την αντιμετωπιση του καρκινου ή της ηπατικης ινωσης | |
ATE156839T1 (de) | Neue delta-17 und delta-20 ungesätigte und gesatigte 17--g(b)-substituierte-4-aza-5-g(a)- androstan-3-on verbindungen als inhibitoren von 5-alpha-reductase | |
MX9606503A (es) | Inhibidores de pla2 y su uso para la inhibicion de la absorcion del colesterol interno. | |
PL340561A1 (en) | Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders | |
MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
IL150125A0 (en) | Novel compounds | |
RS92304A (en) | Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retention | |
AU1023497A (en) | Tissue factor - kunitz domain fusion proteins as factor viia inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19961223 |